rts logo

Supernus Pharmaceuticals Inc (SUPN) Review – Making Smarter Decisions

Supernus Pharmaceuticals Inc (NASDAQ: SUPN) is 3.66% higher on its value in year-to-date trading and has touched a low of $21.99 and a high of $38.08 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SUPN stock was last observed hovering at around $31.30 in the last trading session, with the day’s loss setting it -1.3%.

Currently trading at $30.00, the stock is -0.49% and -5.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.07 million and changing -4.15% at the moment leaves the stock 3.12% off its SMA200. SUPN registered -17.08% loss for a year compared to 6-month gain of 25.73%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -5.78% loss in the last 1 month and extending the period to 3 months gives it a 7.53%, and is -0.89% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.20% over the week and 3.94% over the month.

Supernus Pharmaceuticals Inc (SUPN) has around 652 employees, a market worth around $1.65B and $597.40M in sales. Fwd P/E is 14.31. Profit margin for the company is -2.60%. Distance from 52-week low is 36.43% and -21.21% from its 52-week high. The company has generated returns on investments over the last 12 months (-1.61%).

The EPS is expected to shrink by -25.71% this year

The shares outstanding are 54.72M, and float is at 52.62M with Short Float at 8.90%.

Supernus Pharmaceuticals Inc (SUPN) Insider Activity

The most recent transaction is an insider sale by Bhatt Padmanabh P., the company’s Sr. VP of IP, CSO. SEC filings show that Bhatt Padmanabh P. sold 14,491 shares of the company’s common stock on Mar 21 ’24 at a price of $35.31 per share for a total of $0.51 million. Following the sale, the insider now owns 8570.0 shares.

Supernus Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 20 ’24 that Bhatt Padmanabh P. (Sr. VP of IP, CSO) sold a total of 400 shares of the company’s common stock. The trade occurred on Mar 20 ’24 and was made at $35.31 per share for $14124.0. Following the transaction, the insider now directly holds 8570.0 shares of the SUPN stock.

Still, SEC filings show that on Mar 19 ’24, Bhatt Padmanabh P. (Sr. VP of IP, CSO) disposed off 12,364 shares at an average price of $35.31 for $0.44 million. The insider now directly holds 8,570 shares of Supernus Pharmaceuticals Inc (SUPN).

Related Posts